HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Waldemar Priebe Selected Research

annamycin

5/2007Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.
1/2006Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells.
5/2005Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells.
7/2002Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Waldemar Priebe Research Topics

Disease

49Neoplasms (Cancer)
01/2022 - 12/2002
11Glioblastoma (Glioblastoma Multiforme)
01/2022 - 10/2007
11Melanoma (Melanoma, Malignant)
12/2018 - 01/2004
9Glioma (Gliomas)
01/2022 - 01/2010
7Breast Neoplasms (Breast Cancer)
12/2018 - 07/2002
4Brain Neoplasms (Brain Tumor)
12/2018 - 07/2009
4Neoplasm Metastasis (Metastasis)
12/2018 - 07/2002
4Carcinoma (Carcinomatosis)
04/2015 - 05/2005
3Necrosis
04/2015 - 01/2006
3Carcinogenesis
01/2013 - 12/2008
3Hypoxia (Hypoxemia)
01/2011 - 12/2002
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2007 - 05/2005
2COVID-19
10/2021 - 08/2021
2Infections
10/2021 - 08/2021
2Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 10/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2018 - 01/2004
2Ewing Sarcoma (Sarcoma, Ewing)
01/2017 - 12/2016
2Prostatic Neoplasms (Prostate Cancer)
04/2015 - 01/2011
2Leukemia
12/2011 - 04/2007
2Squamous Cell Carcinoma of Head and Neck
07/2011 - 01/2009
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2011 - 01/2009
2Colonic Neoplasms (Colon Cancer)
01/2011 - 01/2005
2Hematologic Neoplasms (Hematological Malignancy)
12/2007 - 03/2007
2Lung Neoplasms (Lung Cancer)
10/2007 - 01/2004
2Polyploidy
01/2006 - 02/2003
2Osteosarcoma (Osteogenic Sarcoma)
01/2004 - 12/2002
1Disease Progression
01/2022
1Adenocarcinoma
10/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2019

Drug/Important Bio-Agent (IBA)

14Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017 - 07/2002
11WP1066IBA
01/2022 - 12/2007
10AnthracyclinesIBA
10/2017 - 01/2004
9Pharmaceutical PreparationsIBA
04/2020 - 10/2004
8Proteins (Proteins, Gene)FDA Link
12/2018 - 01/2006
8STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
09/2012 - 12/2008
7WP 631IBA
04/2015 - 04/2002
5CytokinesIBA
12/2014 - 05/2005
5Deoxyglucose (2 Deoxy D glucose)IBA
07/2011 - 12/2002
4Antineoplastic Agents (Antineoplastics)IBA
11/2021 - 03/2007
4Glucose (Dextrose)FDA LinkGeneric
04/2021 - 12/2006
4Type II DNA Topoisomerases (Topoisomerase II)IBA
12/2014 - 05/2005
4annamycinIBA
05/2007 - 07/2002
3EnzymesIBA
01/2022 - 12/2018
3DNA (Deoxyribonucleic Acid)IBA
12/2018 - 05/2005
3degrasynIBA
01/2014 - 04/2007
3Janus KinasesIBA
01/2014 - 02/2008
3alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
06/2012 - 02/2008
3WP 1193IBA
05/2012 - 01/2010
3Phosphotransferases (Kinase)IBA
09/2011 - 12/2007
2Cytotoxins (Cytolysins)IBA
11/2021 - 12/2014
2Antiviral Agents (Antivirals)IBA
10/2021 - 08/2021
2MicroRNAs (MicroRNA)IBA
10/2021 - 08/2021
2Phosphopyruvate Hydratase (Enolase)IBA
01/2021 - 12/2020
2Daunorubicin (Cerubidine)FDA LinkGeneric
10/2017 - 04/2007
2WP760IBA
10/2017 - 10/2007
2LigandsIBA
05/2017 - 01/2017
2Insulin (Novolin)FDA Link
01/2017 - 09/2011
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2016 - 04/2009
2epidermal growth factor receptor VIIIIBA
12/2014 - 01/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014 - 12/2007
2Interleukin-6 (Interleukin 6)IBA
01/2014 - 01/2010
2Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
09/2012 - 12/2010
2Janus Kinase 2IBA
05/2012 - 04/2009
2Paclitaxel (Taxol)FDA LinkGeneric
01/2011 - 01/2004
2Transcription Factors (Transcription Factor)IBA
12/2007 - 01/2005
2Biological ProductsIBA
05/2007 - 07/2003
2multidrug resistance-associated protein 1IBA
04/2007 - 04/2007
2Cisplatin (Platino)FDA LinkGeneric
07/2003 - 01/2003
1HexokinaseIBA
01/2022
1Histone Deacetylases (Histone Deacetylase)IBA
11/2021
1Valproic Acid (Depakote)FDA LinkGeneric
11/2021
1Butyric Acid (Butanoic Acid)IBA
11/2021
1Histone Deacetylase InhibitorsIBA
11/2021
1Mannose (D-Mannose)IBA
04/2021
1AntigensIBA
04/2020
1Eph Family Receptors (Eph Receptors)IBA
04/2020
1Therapeutic UsesIBA
01/2020
1Pyruvic Acid (Pyruvate)IBA
10/2019
1Contrast MediaIBA
10/2019
1Lactic Acid (Lactate)FDA LinkGeneric
10/2019
1Auranofin (Ridaura)FDA Link
10/2019
13,6-di-O-acetyl-2-deoxy-D-glucopyranoseIBA
10/2019
1CarbonIBA
10/2019
1Antirheumatic Agents (DMARD)IBA
10/2019
1ExotoxinsIBA
05/2017
1Nuclear Localization Signals (Nuclear Localization Signal)IBA
05/2017
1Tumor Viral Antigens (Large T Antigen)IBA
05/2017
1Interleukin-13IBA
05/2017
1Somatomedin Receptors (Somatomedin Receptor)IBA
12/2016
1TOR Serine-Threonine KinasesIBA
12/2016
1Drug CombinationsIBA
12/2016
1Sepharose (Agarose)IBA
02/2016

Therapy/Procedure

18Therapeutics
10/2019 - 12/2002
4Drug Therapy (Chemotherapy)
12/2018 - 01/2010
3Radiotherapy
01/2022 - 01/2010
3Immunotherapy
05/2010 - 10/2007
2Aftercare (After-Treatment)
10/2019 - 07/2002
1Intravenous Injections
10/2019
1Bioreactors (Bioreactor)
01/2017
1Traction
01/2017